| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 09/28/2010 | CA2380298C Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof |
| 09/28/2010 | CA2323503C Novel physiological active peptide and its use |
| 09/28/2010 | CA2286288C Monoclonal antibody recognizing the n-glycolylated-galacotose-glucose sialic acid oligosaccharide in malignant tumors and composition that contains it |
| 09/28/2010 | CA2285746C Osteoprotegerin binding proteins and receptors |
| 09/28/2010 | CA2235866C Methods of treating established colitis using antibodies against il-12 |
| 09/28/2010 | CA2208783C Methods for producing immunoglobulins containing protection proteins in plants and their use |
| 09/28/2010 | CA2188017C Cardiotrophin and uses therefor |
| 09/28/2010 | CA2153494C Novel parasitic helminth proteins |
| 09/23/2010 | WO2010107110A1 Antibody constant region variant |
| 09/23/2010 | WO2010107109A1 Antibody constant region variant |
| 09/23/2010 | WO2010107068A1 METHOD FOR MEASURING β-GLUCAN, AND β-GLUCAN-BINDING PROTEIN FOR USE IN THE METHOD |
| 09/23/2010 | WO2010106437A1 Peptides that inhibit angiotensin converting enzyme and peptides with antioxidant activity purified from ovotransferrin and methods of producing and using the same |
| 09/23/2010 | WO2010105573A1 Anti-angiogenic fusion proteins |
| 09/23/2010 | US20100240873 Ligand (act-4-l) to a receptor on the surface of activated cd4+ tcells |
| 09/23/2010 | US20100240871 Galactose Alpha(1-3) Galactose Compositions |
| 09/23/2010 | US20100240866 Modified gherlin peptides |
| 09/23/2010 | US20100240597 Methods of delivery of molecules to cells using a ricin subunit and compositions relating to same |
| 09/23/2010 | US20100240583 Soluble protein and utilization of the same |
| 09/23/2010 | US20100240575 Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same |
| 09/23/2010 | US20100240146 Fluorescent protein particles |
| 09/23/2010 | US20100240100 Human antibodies that have mn binding and cell adhesion-neutralizing activity |
| 09/23/2010 | US20100240099 rBSA from K. lactis Expression, Secretion and Purification of Recombinant Bovine Serum Albumin (rBSA) from K. lactis and uses thereof |
| 09/23/2010 | US20100240097 Mammalian expression vector with a highly efficient secretory signal sequence |
| 09/23/2010 | US20100240096 Novel hemopoietin receptor protein, nr10 |
| 09/23/2010 | US20100240095 Polypeptides having cellobiohydrolase II activity and polynuleotides encoding same |
| 09/23/2010 | US20100240065 Prolyl Hydroxylase Compositions and Methods of Use Thereof |
| 09/23/2010 | US20100239594 Compositions and methods for production of immunoglobulins |
| 09/23/2010 | US20100239593 Rsv-specific binding molecules and means for producing them |
| 09/23/2010 | US20100239577 Anti-glypican-3 antibody having improved kinetics in plasma |
| 09/23/2010 | US20100239575 Anti-cd40 antibodies and uses thereof |
| 09/23/2010 | US20100239574 High potency recombinant antibodies and method for producing them |
| 09/23/2010 | US20100239570 Moncolonal amyloid beta (abeta) - specific antibody and uses thereof |
| 09/23/2010 | US20100239530 Ifnar2 mutants, their production and use |
| 09/23/2010 | CA2793800A1 Peptides that inhibit angiotensin converting enzyme and peptides with antioxidant activity purified from ovotransferrin and methods of producing and using the same |
| 09/23/2010 | CA2755417A1 New fungal production system |
| 09/22/2010 | EP2230335A2 Method to screen phage display libraries with different ligands |
| 09/22/2010 | EP2230308A1 Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof |
| 09/22/2010 | EP2230307A1 Neutrokine alpha |
| 09/22/2010 | EP2230300A1 Polypeptide having enhanced effector function |
| 09/22/2010 | EP2230299A1 Novel cytokine ZCYTOR17 ligand |
| 09/22/2010 | EP2230250A1 Anti-hiv monoclonal antibody |
| 09/22/2010 | EP2229956A1 Multimeric constructs |
| 09/22/2010 | EP2229432A1 Antimicrobial activity of bacteriocin-producing lactic acid bacteria |
| 09/22/2010 | EP1335938B1 Apolipoprotein construct |
| 09/22/2010 | EP1133565B1 Generation of specific binding partners binding to (poly)peptides encoded by genomic dna fragments or ests |
| 09/22/2010 | CN101842479A Signal sequences and co-expressed chaperones for improving protein production in a host cell |
| 09/22/2010 | CN101842117A Anti-IGF-1R antibodies and uses thereof |
| 09/22/2010 | CN101838661A Preparation method of high stability phycocyanin fuse fluorescent protein |
| 09/22/2010 | CN101838651A Construction method of gene engineering strain expressing pig alpha-interferon |
| 09/22/2010 | CN101838628A Method for producing L-amino acids using bacteria belonging to the genus escherichia |
| 09/22/2010 | CN101838621A Method for preparing bacillus subtilis lipopeptid biosurfactant |
| 09/22/2010 | CN101838467A Novel chitosan nanoparticles and preparation method thereof |
| 09/22/2010 | CN101838329A Anti-angiogenesis fusion protein |
| 09/22/2010 | CN101838328A Anti-vegf antibodies |
| 09/22/2010 | CN101838325A Antigen-presenting protein for swines and encoding gene and application thereof |
| 09/22/2010 | CN101838318A Anti-HIV-I polypeptide and coding sequence and use thereof |
| 09/22/2010 | CN101838314A Preparation of cyclic lipopeptide compound and application thereof |
| 09/21/2010 | US7799901 capable of modulating or mediating the FAS receptor ligand or TNF effect on cells carrying FAS receptor or p55 receptor by binding or interacting with MORT-1 (mediators of receptor toxicity) protein |
| 09/21/2010 | US7799900 humanized and chimeric anti-CD20 antibodies for treatment of CD20 positive malignancies and autoimmune diseases; treatment of B-cell associated diseases |
| 09/21/2010 | US7799759 albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins |
| 09/21/2010 | US7799552 Vector for use as a tool in tranfer and express of preferential nucleotide sequences |
| 09/21/2010 | US7799543 Human tumor necrosis factor receptor polynucleotides |
| 09/21/2010 | US7799542 Apparatus for arbitrary peptide synthesis |
| 09/21/2010 | US7799541 for Systemic Inflammatory Response Syndrome (SIRS), including severe sepsis, septic shock and sepsis related to cardiac dysfunction |
| 09/21/2010 | US7799529 Nephrin gene and protein |
| 09/21/2010 | US7799327 Employing nonimmunogenic blood products from patients with autoimmune disease |
| 09/21/2010 | CA2384880C Methods for making recombinant proteins using apoptosis inhibitors |
| 09/21/2010 | CA2369292C Method of modulating the activity of functional immune molecules |
| 09/21/2010 | CA2367457C Protein for blocking platelet adhesion |
| 09/21/2010 | CA2345403C Detection of preharvest sprouting in cereal grains |
| 09/21/2010 | CA2308791C Method to screen phage display libraries with different ligands |
| 09/21/2010 | CA2192694C Cloning and expression of an acetylcholine-gated ion channel receptor subunit |
| 09/16/2010 | WO2010105227A1 Methods of renaturation of recombinant proteins |
| 09/16/2010 | WO2010105068A1 Ox40/trail fusion proteins |
| 09/16/2010 | WO2010104836A1 Infectious disease cellular immunotherapy |
| 09/16/2010 | WO2010104821A1 Mirac proteins |
| 09/16/2010 | WO2010104208A1 Generation, expression and characterization of the humanized k33n monoclonal antibody |
| 09/16/2010 | WO2010102982A1 Method for improving the yield of a polypeptide |
| 09/16/2010 | WO2010102976A1 Pregastric esterase and derivatives thereof |
| 09/16/2010 | WO2010102886A1 Modification of factor viii |
| 09/16/2010 | WO2010062399A8 Csf1r extracellular domain fusion molecules and treatments using same |
| 09/16/2010 | WO2010054265A3 Monoclonal antibodies to fibroblast growth factor receptor 2 |
| 09/16/2010 | US20100235933 Kaspp (lrrk2) gene, its production and use for the detection and treatment of neurodegenerative disorders |
| 09/16/2010 | US20100235929 Compositions and Methods for Producing Antibodies Having Human Idiotypes in Transgenic Birds |
| 09/16/2010 | US20100234581 Thermostable xylose isomerase enzymes |
| 09/16/2010 | US20100234578 Anti-cd40 monoclonal antibody |
| 09/16/2010 | US20100234293 Novel Neurotrophic Factors |
| 09/16/2010 | US20100233819 Robo: a novel family of polypeptides and nucleic acids |
| 09/16/2010 | US20100233761 Algae biomass fractionation |
| 09/16/2010 | US20100233760 Protein Production in Microorganisms of the Phylum Labyrinthulomycota |
| 09/16/2010 | US20100233759 Method for production of polypeptide |
| 09/16/2010 | US20100233758 Protein increasing cell infectivity of herpes simplex virus and use thereof |
| 09/16/2010 | US20100233757 Synthesis and Use of Anti-Reverse Phosphorothioate Analogs of the Messenger RNA Cap |
| 09/16/2010 | US20100233711 Gene encoding labyrinthin, a marker for cancer |
| 09/16/2010 | US20100233219 Inorganic nanoparticle compromising an active substance immobilized on the surface and a polymer |
| 09/16/2010 | US20100233195 Compositions and methods for the display of proteins on the surface of bacteria and their derived vesicles and uses thereof |
| 09/16/2010 | US20100233186 Novel receptor that binds ctla-8 |
| 09/16/2010 | US20100233175 Antibodies relating to pivkaii and uses thereof |
| 09/16/2010 | US20100233169 Methods for treating obesity using fibroblast growth factor-Like polypeptides |
| 09/16/2010 | US20100233157 Human antibodies against human fas and their use |